UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
October 12, 2017
Accession Number:
Submission Type:
CIK:
0001388320
Company Name:
Actinium Pharmaceuticals, Inc.
File Number:
333-216748